Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 4051 AL 4065

Salsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments

Kurnik-Łucka M, Panula P, Bugajski A, Gil K.

Neurotox Res. 2018 Feb;33(2):485-514. doi: 10.1007/s12640-017-9818-6. Epub 2017 Oct 23.

Differential contribution of microglia and monocytes in neurodegenerative diseases

Baufeld C, O'Loughlin E, Calcagno N, Madore C, Butovsky O.

J Neural Transm (Vienna). 2018 May;125(5):809-826. doi: 10.1007/s00702-017-1795-7. Epub 2017 Oct 23.

Molecular mechanisms of α-synuclein and GBA1 in Parkinson's disease

Stojkovska I, Krainc D, Mazzulli JR.

Cell Tissue Res. 2018 Jul;373(1):51-60. doi: 10.1007/s00441-017-2704-y. Epub 2017 Oct 24.

Electrophysiological effects of desflurane in children with Wolff-Parkinson-White syndrome: a randomized crossover study

Hino H, Oda Y, Yoshida Y, Suzuki T, Shimada M, Nishikawa K.

Acta Anaesthesiol Scand. 2018 Feb;62(2):159-166. doi: 10.1111/aas.13023. Epub 2017 Oct 25.

A review of genome-wide transcriptomics studies in Parkinson's disease

Borrageiro G, Haylett W, Seedat S, Kuivaniemi H, Bardien S.

Eur J Neurosci. 2018 Jan;47(1):1-16. doi: 10.1111/ejn.13760. Epub 2017 Nov 22.

Active exergames to improve cognitive functioning in neurological disabilities: a systematic review and meta-analysis

Mura G, Carta MG, Sancassiani F, Machado S, Prosperini L.

Eur J Phys Rehabil Med. 2018 Jun;54(3):450-462. doi: 10.23736/S1973-9087.17.04680-9. Epub 2017 Oct 25.

Updates on immunity and inflammation in Parkinson disease pathology

Joshi N, Singh S.

J Neurosci Res. 2018 Mar;96(3):379-390. doi: 10.1002/jnr.24185. Epub 2017 Oct 26.

The prevalence, course and clinical correlates of migraine in Parkinson's disease: A multicentre case-controlled study

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Suzuki S, Haruyama Y, Kobashi G, Hirata K; Kanto NMPD investigators.

Cephalalgia. 2018 Aug;38(9):1535-1544. doi: 10.1177/0333102417739302. Epub 2017 Oct 26.

Are rodent models of Parkinson's disease behaving as they should?

Vingill S, Connor-Robson N, Wade-Martins R.

Behav Brain Res. 2018 Oct 15;352:133-141. doi: 10.1016/j.bbr.2017.10.021. Epub 2017 Oct 24.

Functional amyloids: interrelationship with other amyloids and therapeutic assessment to treat neurodegenerative diseases

Som Chaudhury S, Das Mukhopadhyay C.

Int J Neurosci. 2018 May;128(5):449-463. doi: 10.1080/00207454.2017.1398153. Epub 2017 Nov 16.

Unilateral Vocal Fold Paralysis in Parkinson Disease: Case Report and Review of the Literature

Hamdan AL, Khalifee E, Tabet G.

J Voice. 2018 Nov;32(6):763-766. doi: 10.1016/j.jvoice.2017.09.007. Epub 2017 Nov 1.

OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia

Farhan SMK, Gendron TF, Petrucelli L, Hegele RA, Strong MJ.

Am J Med Genet B Neuropsychiatr Genet. 2018 Jan;177(1):75-85. doi: 10.1002/ajmg.b.32606. Epub 2017 Oct 28.

Cytotherapy using stromal cells: Current and advance multi-treatment approaches

Shende P, Gupta H, Gaud RS.

Biomed Pharmacother. 2018 Jan;97:38-44. doi: 10.1016/j.biopha.2017.10.127. Epub 2017 Nov 6.

Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway

Frandsen JR, Narayanasamy P.

Redox Biol. 2018 Apr;14:465-473. doi: 10.1016/j.redox.2017.10.015. Epub 2017 Oct 18.

A multi-biomarker analysis of the antioxidant efficacy of Parkinson's disease therapy

Colamartino M, Duranti G, Ceci R, Sabatini S, Testa A, Cozzi R.

Toxicol In Vitro. 2018 Mar;47:1-7. doi: 10.1016/j.tiv.2017.10.020. Epub 2017 Oct 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias